Raleigh Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-400	Closed	-$20.4K	–	1029
2024 Q3	$20.4K	Buy	+400	New	+$20.4K	0.01%	433